Ketamine disrupts abnormal brain activity, offering long-term relief for Parkinson’s dyskinesia in early clinical trials.

This insightful interactive webinar delves into the motor and non-motor symptoms experienced by patients with Parkinson’s ...

You can’t start a company without a healthy dose of daring, and that’s certainly the case with NeuroBionics. The MIT-spinout ...

The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Virtual reality VR is a simulated three-dimensional 3D environment that enables users to explore and engage with virtual ...

Scientists discover popular sleep aids might prevent your brain from clearing dangerous waste during sleep. Learn the risks ...

For Michel Roccati, who was paralyzed after a motorcycle accident, NeuroRestore’s technology provided a life-changing ...

MedRhythms, Inc. today announced that InTandem®, the company's flagship rehabilitation system for chronic stroke gait impairment, received a final pricing determination from the Centers for Medicare ...

Acadia Pharmaceuticals ACAD announced that it has submitted a marketing authorization application (MAA) to the European ...

One of the benefits of attending Monmouth University for music students is the school's own record label, Blue Hawk Records. A concert will take place in Asbury Park Thursday at 7 p.m. The Monmouth ...

Have you ever reread a text message, wondering if it was taken the wrong way? Or sent an email only to receive no reply, ...

Medtronic CEO Geoff Martha discusses innovations such as pulse field ablation, renal denervation, DBS, diabetes tech and ...